Is GC running out of ideas to increase the price.19 Aug 2021 13:01
Tils seem to be trying everything to get the price higher.
1. Posts good covid data results although a small data set.
2. Announces a Phase 2 covid trial to start soon.
3. Other positive pipeline plans updated.
4. Investor presentations galore.
And still the price is sub 60p.
What will it take to get the price over £1 and then.£2?
I personally believe this is it until Tils move onto a Phase 3 trial. Until there is a sniff of commercialisation this price is going to drift further or see saw between 50p and 70p. Such a shame with all the promises made. This was pumped so much last year by the company and a select few on here, facebook and twitter. Looks like that pumping has damaged the integrity of the company and many don't trust it anymore to rise just on it's own back.
"The options that have been exercised were due to expire in September 2021. Certain of the new ordinary shares have been sold, at a price of 140p, to meet the tax and subscription costs associated with the exercise, with the remaining shares being retained by the directors.'